Dr Gareth Healey
Project Manager
Telephone: (01792) 606474
Room: Meeting Room Enteprise & Innovation - 003
Ground Floor
Institute of Life Science 1
Singleton Campus

Areas of Expertise

  • Immunology
  • Molecular biology
  • Drug development
  • Reproductive biology
  • Gynaecological cancer
  • Project Management


  1. & Isoprenoids increase bovine endometrial stromal cell tolerance to the cholesterol-dependent cytolysin from Trueperella pyogenes†. Biology of Reproduction
  2. & Maternal metabolism affects endometrial expression of oxidative stress and FOXL2 genes in cattle. PLOS ONE 12(12), e0189942
  3. & Therapeutic Development and the Evolution of Precision Medicine. In Nanoscience and Nanotechnology for Human Health. (pp. 359-378).
  4. & Antibody–drug conjugates and other nanomedicines: the frontier of gynaecological cancer treatment. Interface Focus 6(6), 20160054
  5. Mevalonate Biosynthesis Intermediates Are Key Regulators of Innate Immunity in Bovine Endometritis. The Journal of Immunology 196(2), 823-831.

See more...


  • PMNM04 Nanomedicines and Therapeutics

    The module will explore the history and development of molecular medicines. Using landmark technology and chemical development phases, the traditional small chemical entities using in molecular medicine will be outlined, using drugs such as taxols and tamoxifen as exemplars. The common target oncology and non oncology disorders will outlined and their respective targets for such medicines detailed alongside drug modes of action and delivery (IV and oral). Further exploration of targeted nanoparticle delivery, from early first generation drugs such as Abraxane to second generation biologically targeted SMART delivery systems, will expand the knowledge to future molecular medicines such as antibody drug conjugates and kinase inhibitors. Excitingly the module will include guest lectures from industry and clinicians, covering the spectrum of drug development to delivery and clinical considerations.

Research Groups